Wondering how a lab can change one spot in a genome? CRISPR gene editing explained in one line: a guide RNA steers a DNA-cutting protein to a matching sequence, and the cell’s own repair makes the edit.
| Item | Value |
|---|---|
| Typical Cas9 target length | 20 nucleotides, followed by a PAM |
| PAM used by the most widely used Cas9 | 5′-NGG-3′ |
| Main repair routes after a cut | NHEJ and HDR |
| Editors that avoid double-strand breaks | Base editors and prime editors |
| Mismatch types some guides tolerate | DNA bulge and sgRNA bulge |
These figures come from a PubMed Central review of Cas9 specificity and a Nature Communications review. They can change as the field moves, so check the sources before you rely on them.
CRISPR gene editing: what it is and how the cut is aimed
CRISPR began as a bacterial defence system. Researchers adapted it into a programmable tool that works in many cell types. This is one of the core methods behind modern what is biotechnology work, so it helps to see it as a lab technique first.
The tool has two parts. According to a PubMed-indexed study of off-target effects, these are “ribonucleoproteins that consist of guide RNA and Cas9”. The guide RNA matches a DNA sequence, and Cas9 cuts there.
The most widely used Cas9 “targets a 20 nucleotide DNA sequence immediately followed by a 5′-NGG-3′ protospacer-adjacent motif (PAM)”, as the PubMed Central review describes. The PAM requirement limits where the standard tool can cut.
Cut, repair, edit: what happens inside the cell
Cas9 makes a double-strand break. The edit itself comes from the cell’s repair, which the Nature Communications review says is “repaired predominantly by non-homologous end-joining pathway (NHEJ) and homology-directed repair (HDR)”.
- NHEJ often leaves small insertions or deletions, which can disrupt a gene.
- HDR can copy in a new sequence if researchers supply a donor template.
- Base and prime editors aim to change single letters without a double-strand break or donor template.
Which route the cell uses depends on the cell type and conditions. That is one reason results vary between experiments.
Why off-target edits matter
Guide RNAs can tolerate some mismatches, so Cas9 may cut similar sites elsewhere. The PubMed Central review notes that “some sgRNAs can also tolerate DNA sequences with an extra base (DNA bulge) or a missing base (sgRNA bulge)”.
Studies disagree on how often this happens. A genome-wide study reported that Cas9 nucleases “can be highly specific, inducing off-target mutations at merely several, rather than thousands of, sites”. The same abstract says genome-wide target specificities of Cas9 nucleases “remain controversial”.
Researchers reduce the risk in several ways:
- Choose unique target sequences in the genome.
- Modify the guide RNA or the Cas9 protein.
- Use paired nickases, which make two single-strand nicks instead of one double-strand cut.
- Check results with genome-wide detection methods.
Off-target effects fell “below the detection limits of deep sequencing” in one study that did this, according to the same PubMed record. That is a statement about detection limits, not proof that no unintended edits exist.
How researchers measure off-target risk
Measuring unintended edits is a research problem of its own. In one genome-wide study, off-target sites were validated with insertion and deletion frequencies below 0.1%, which the authors describe as near the detection limit of targeted deep sequencing.
That detail matters. A very rare edit can be real and still be hard to see, so a clean result depends on the sensitivity of the assay. A negative result means “not detected by this method”, which is a weaker statement than “absent”.
The Nature Communications review cautions that detection methods may not fully mimic editor delivery and chromatin state in target cells.
Choosing a guide: design trade-offs
Choosing unique target sequences and modifying both guide RNA and Cas9 reduced off-target effects below deep sequencing detection limits in the PubMed-indexed nickase study.
Other design choices change the picture as well:
- Guide RNA modifications: changes to the guide RNA can alter how it behaves, as the PubMed-indexed nickase study reported.
- Protein variants: paired Cas9 nickases were highly specific in human cells in the same study.
None of these choices removes uncertainty. They shift the balance, and the right setting depends on the experiment and on what level of unintended change is acceptable for the question being asked.
What CRISPR can and cannot do
CRISPR is good at making targeted changes in cells you can reach and measure. It is less suited to jobs that need perfect precision.
- Can: knock out genes, install defined changes and test what a gene does in cell and animal models.
- Cannot reliably: ensure that every cell is edited, or rule out every unintended change.
- A limitation of detection methods: The Nature Communications review says detection methods “may still not fully mimic the editor delivery and chromatin state expected in target cells”.
Finding unintended changes often relies on sequencing. Our guide to next generation sequencing explained covers the technique that many off-target checks use.
From the lab bench to a clinical product
A review of sickle cell therapeutics lists “Casgevy/Exa-cel (approved in 2023)”. It also says the cells “were edited with clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 targeting the BCL11A protein”, per the same review.
This is a neutral example of how the method has been used, not a claim about outcomes for any person. Edited cell products are a different kind of product from antibodies or pills. For that contrast, see biologics vs small molecule drugs.
This site does not give medical advice. Anyone considering a clinical therapy should talk to a qualified clinician.
Frequently asked questions
Is CRISPR the same as Cas9?
Show answer
No. CRISPR names the system, and Cas9 is one protein used in it. The editor is made of Cas9 plus a guide RNA, as the PubMed-indexed study above describes.
Does CRISPR always cut the right place?
Show answer
Not always. Guides can tolerate mismatches, and published studies differ on how often unintended cuts occur. Careful guide design and high-specificity variants reduce, but may not remove, the risk.
What is the difference between NHEJ and HDR?
Show answer
NHEJ is a quick repair that often leaves small insertions or deletions. HDR can use a supplied template to write a defined sequence.
Do base editors and prime editors replace Cas9?
Show answer
They are alternatives for some jobs. They aim to install point changes without a double-strand break, but they bring their own limits, and the Nature Communications review discusses their precision and safety.
This article is for information only. It is general education about science and the drug industry, and it is not medical, treatment or investment advice.
